122 related articles for article (PubMed ID: 5030847)
1. [Polychemotherapy of acute leukemias in children and adolescents].
Ochme J; Kötz F
Dtsch Med Wochenschr; 1972 Jun; 97(23):908-11. PubMed ID: 5030847
[No Abstract] [Full Text] [Related]
2. [Induction and interval treatment of leukemias in children and juveniles].
Oehme J; Meyer-Beeck D
Dtsch Med Wochenschr; 1969 Sep; 94(39):1993-6. PubMed ID: 5352272
[No Abstract] [Full Text] [Related]
3. Prognostic impact of IKZF1 deletions in association with vincristine-dexamethasone pulses during maintenance treatment of childhood acute lymphoblastic leukemia on trial ALL-BFM 95.
Hinze L; Möricke A; Zimmermann M; Junk S; Cario G; Dagdan E; Kratz CP; Conter V; Schrappe M; Stanulla M
Leukemia; 2017 Aug; 31(8):1840-1842. PubMed ID: 28529312
[No Abstract] [Full Text] [Related]
4. Risk groups in a multicenter pilot study for treatment of acute lymphoblastic and acute undifferentiated leukemia in adults.
Hoelzer D; Thiel E; Löffler H; Bodenstein H; Büchner T; Engelhardt R; Ganser A; Messerer D; Rühl H; Zwingers T
Haematol Blood Transfus; 1985; 29():48-50. PubMed ID: 3861487
[No Abstract] [Full Text] [Related]
5. Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial.
Attarbaschi A; Mann G; Zimmermann M; Bader P; Barisone E; Basso G; Biondi A; Cario G; Cazzaniga G; Colombini A; Flotho C; Kuhlen M; Lang P; Lauten M; Linderkamp C; Locatelli F; Lo Nigro L; Möricke A; Niggli F; Panzer-Grümayer R; Parasole R; Peters C; Caterina Putti M; Rizzari C; Suttorp M; Valsecchi MG; Conter V; Schrappe M;
Leukemia; 2020 Jun; 34(6):1694-1700. PubMed ID: 31806872
[No Abstract] [Full Text] [Related]
6. Intensive chemotherapy in children with acute lymphoblastic leukemia (L-2 protocol).
Haghbin M; Tan CC; Clarkson BD; Miké V; Burchenal JH; Murphy ML
Cancer; 1974 Jun; 33(6):1491-8. PubMed ID: 4526012
[No Abstract] [Full Text] [Related]
7. [Investigations in the use of mogramostime (GM-CSF) in patients with acute leukemia].
Paśnicki M
Wiad Lek; 1995; 48(1-12):194-7. PubMed ID: 9638239
[No Abstract] [Full Text] [Related]
8. Improved prognosis for childhood acute lymphocytic leukemia with very high white blood cell count (greater than 100/nl) with rotation of non-cross-resistant drug combinations.
Janka-Schaub GE; Goebel U; Graubner U; Haas RJ; Juergens H; Spaar HJ; Winkler K
Haematol Blood Transfus; 1990; 33():489-93. PubMed ID: 2182442
[No Abstract] [Full Text] [Related]
9. Increased factor VIII activity and dural sinus thrombosis.
Celkan T; Ozkan A; Apak H; Kuruoglu S; Yuksel L; Yildiz I
Med Pediatr Oncol; 2002 Jul; 39(1):71-2. PubMed ID: 12116089
[No Abstract] [Full Text] [Related]
10. Neurological complications during treatment of childhood cancer: mind Wernicke encephalopathy.
La Spina M; Catania R; Lo Nigro L; De Grandi C; Palmucci S; Di Cataldo A
Pediatr Hematol Oncol; 2010 May; 27(4):320-3. PubMed ID: 20426524
[No Abstract] [Full Text] [Related]
11. [Polychemotherapy of acute leukemias in children and young persons].
Oehme J; Kötz F
Minerva Med; 1973 Mar; 64(14):655-60. PubMed ID: 4707821
[No Abstract] [Full Text] [Related]
12. Evaluation of intensification and maintenance programs in the treatment of acute lymphoblastic leukemia.
Sackmann-Muriel F; Svarch E; Eppinger-Helft M; Braier JL; Pavlovsky S; Guman L; Vergara B; Ponzinibbio C; Failace R; Garay GE; Bugnard E; Ojeda FG; De Bellis R; de Sijvarger SR; Saslavsky J
Cancer; 1978 Oct; 42(4):1730-40. PubMed ID: 101296
[TBL] [Abstract][Full Text] [Related]
13. A study of intermittent alternating drug program reinduction therapy on the frequency and duration of response in adult acute leukemia.
McCredie KB; Freireich EJ; Bodey GP; Burgess MA; Whitecar JP; Smith TL
Med Pediatr Oncol; 1976; 2(3):309-18. PubMed ID: 979915
[TBL] [Abstract][Full Text] [Related]
14. [Results of modified LSA2-L2 protocol with moderate-dose MTX therapy in children with untreated non-Hodgkin's lymphoma].
Shimamoto Y; Imai S; Endo N
Gan To Kagaku Ryoho; 1992 Mar; 19(3):395-8. PubMed ID: 1543367
[No Abstract] [Full Text] [Related]
15. Variant translocations of 11q23 in infant acute lymphoblastic leukemia (ALL): do outcomes differ from t(4;11)?
Jakab Z; Balogh E; Karászi E; Kappelmayer J; Kiss C; Oláh E
Med Pediatr Oncol; 2002 Jul; 39(1):63-5. PubMed ID: 12116086
[No Abstract] [Full Text] [Related]
16. Maintenance therapy in acute leukemia of childhood. Comparison of cyclic vs. sequential methods.
Krivit W; Brubaker C; Thatcher LG; Pierce M; Perrin E; Hartmann JR
Cancer; 1968 Mar; 21(3):352-6. PubMed ID: 5637946
[No Abstract] [Full Text] [Related]
17. Benign intracranial hypertension in association with acute lymphoblastic leukemia.
Sastry J; Karandikar SS; English MW
Pediatr Hematol Oncol; 2003 Mar; 20(2):157-60. PubMed ID: 12554527
[No Abstract] [Full Text] [Related]
18. Therapy of acute leukemia with drug combinations which include asparaginase.
Leventhal BG; Henderson ES
Cancer; 1971 Oct; 28(4):825-9. PubMed ID: 5286445
[No Abstract] [Full Text] [Related]
19. Selecting drug regimens in human leukemia.
Hall TC
Natl Cancer Inst Monogr; 1971 Dec; 34():145-51. PubMed ID: 5291098
[No Abstract] [Full Text] [Related]
20. Chemoimmunotherapy in acute myelocytic leukemia.
Holland JF; Bekesi JG; Cuttner J; Glidewell O
Isr J Med Sci; 1977 Jul; 13(7):694-700. PubMed ID: 270473
[No Abstract] [Full Text] [Related]
[Next] [New Search]
